Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217522 · ClinicalTrials.gov registry record
Rutgers University Study of the Genetics of Pulmonary Hypertension
A clinical trial of Pulmonary Hypertension and Pulmonary Arterial Hypertension, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT07217522 is a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10,000 participants, above the 475-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (2005% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07217522, a study of Pulmonary Hypertension and Pulmonary Arterial Hypertension, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Conditions Studied
Interventions
- GENETIC Saliva sample
- OTHER Health surveys
Study Locations (1)
New Jersey
- Rutgers University, Piscataway, New Jersey 08854 - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2025-08-23 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217522
The ClinicalTrials.gov registry entry for NCT07217522 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 475-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (2005% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Saliva sample is the first listed.
NCT07217522 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07217522 about?
NCT07217522 is a clinical study titled "Rutgers University Study of the Genetics of Pulmonary Hypertension". The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request...
What is the current status of trial NCT07217522?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2025-08-23. Estimated completion is 2027-12-31.
What conditions does trial NCT07217522 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder), Pulmonary Arterial Hypertension Associated With Connective Tissue Disease, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH).
What interventions are being tested in trial NCT07217522?
The interventions under investigation include: Saliva sample (GENETIC), Health surveys (OTHER).
Who is sponsoring clinical trial NCT07217522?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217522 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.